Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02223286 · ClinicalTrials.gov registry record
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 552
- Enrollment target
NCT02223286 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 552 participants.
The verdict
NCT02223286 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 552 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the use of Corus CAD also known as Age/Sex/Gene Expression score (ASGES) in the clinical decision making process of patients who underwent the evaluation of chest pain or anginal equivalent symptoms. Specifically, to better understand whether the use of the assay in clinical decision making resulted in changes in noninvasive diagnostic test ordering or diagnostic yield of additional tests ordered and/or invasive angiography.
Interventions
- DIAGNOSTIC_TEST Corus CAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 552 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02223286
The ClinicalTrials.gov registry entry for NCT02223286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 552 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioDx, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corus CAD is the first listed.
NCT02223286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02223286 about?
NCT02223286 is a clinical study titled "Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making". The purpose of this study is to understand the use of Corus CAD also known as Age/Sex/Gene Expression score (ASGES) in the clinical decision making process of patients who underwent the evaluation of chest pain or anginal equivalent symptoms. Specifically, to better understand whether the use of the...
What is the current status of trial NCT02223286?
This trial is currently completed. The enrollment target is 552 participants. The study started on 2013-03. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02223286?
The interventions under investigation include: Corus CAD (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02223286?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.